Purpose of Technology
Autologous stem cell therapy for treatment of avascular necrosis (AVN) of the hip involves deriving stem cells from a patient’s own bone marrow or peripheral blood and transplanting them to the necrotic femoral head. Autologous stem cells may be processed and enriched in various ways, and transplantation may occur either surgically, intravenously, or through infusion into a bone graft or scaffold. The goal of this treatment is to preserve the hip joint and promote osteogenesis and angiogenesis in the femoral head.
Does autologous stem cell therapy effectively improve clinical symptoms and slow disease progression?
Does autologous stem cell therapy provide equivalent or superior outcomes compared with other treatments for AVN of the hip?
Is autologous stem cell therapy safe?
Have definitive patient selection criteria been established for autologous stem cell therapy for AVN of the hip?
If you have a Hayes login, click here to view the full report on the Knowledge Center.